1. Home
  2. Research
  3. Research Groups
  4. Infectious Diseases

Infectious Diseases

Search for publications

Only original articles, editorials, guidelines.

  • Norman FF, Monge-Maillo B, Martínez-Pérez Á, Perez-Molina JA, López-Vélez R.

    Parasitic infections in travelers and immigrants: part II helminths and ectoparasites

    Future Microbiology . 10(1): 87-99. Number of citations: 10

    [doi:10.2217/fmb.14.106]

  • Abad-Fernández M, Gutiérrez C, Madrid N, Hernández-Novoa B, Díaz L, Muñoz-Fernández MA, Moreno S, Vallejo A.

    Expression of gut-homing beta 7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?

    HIV MEDICINE . 16(1): 15-23. Number of citations: 1

    [doi:10.1111/hiv.12167]

  • Casado JL, Bañón S, Rodriguez MA, Moreno A, Moreno S.

    Efficacy and pharmacokinetics of the combination of etravirine plus raltegravir as novel dual antiretroviral maintenance regimen in HIV-infected patients

    ANTIVIRAL RESEARCH . 113: 103-106. Number of citations: 12

    [doi:10.1016/j.antiviral.2014.11.006]

  • Casado JL, Machuca I, Bañón S, Moreno A, Moltó J, Rodriguez MA.

    Raltegravir plus two nucleoside analogues as combination antiretroviral therapy in HIV-infected patients who require cancer chemotherapy

    ANTIVIRAL THERAPY . 20(7): 773-777. Number of citations: 9

    [doi:10.3851/IMP2961]

  • Blanco JR, Jarrin I, Martinez A, Siles E, Larrayoz IM, Cañuelo A, Gutierrez F, Gonzalez-Garcia J, Vidal F, Moreno S.

    Shorter Telomere Length Predicts Poorer Immunological Recovery in Virologically Suppressed HIV-1-Infected Patients Treated With Combined Antiretroviral Therapy

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 68(1): 21-29. Number of citations: 20

    [doi:10.1097/QAI.0000000000000398]

  • Schlagenhauf P, Weld L, Goorhuis A, Gautret P, Weber R, von Sonnenburg F, Lopez-Vélez R, Jensenius M, Cramer JP, Field VK, Odolini S, Gkrania-Klotsas E, Chappuis F, Malvy D, van Genderen PJ, Mockenhaupt F, Jauréguiberry S, Smith C, Beeching NJ, Ursing J, Rapp C, Parola P, Grobusch MP.

    Travel-associated infection presenting in Europe (2008-12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation

    LANCET INFECTIOUS DISEASES . 15(1): 55-64. Number of citations: 158

    [doi:10.1016/S1473-3099(14)71000-X]

  • Sobrino-Vegas P, Monge Corella S, Serrano-Villar S, Gutiérrez F, Blanco JR, Santos I, del Romero J, Segura F, Portilla J, Guillén SM, del Amo J.

    Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004-2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions

    Plos One . 9(12): . Number of citations: 18

    [doi:10.1371/journal.pone.0116226]

  • Pascual Á, Pintado V, Rodríguez-Baño J, Miró JM.

    Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 32 Suppl 4: 1-3.

    [doi:10.1016/S0213-005X(14)70167-3]

  • Paño Pardo JR, Serrano Villar S, Ramos Ramos JC, Pintado V.

    Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 32 Suppl 4: 41-48.

    [doi:10.1016/S0213-005X(14)70173-9]

  • Górriz JL, Gutiérrez F, Trullas JC, Arazo P, Arribas JR, Barril G, Cervero M, Cofan F, Domingo P, Estrada V, Fulladosa X, Galindo MJ, Gracia S, Iribarren JA, Knobel H, Lopez-Aldeguer J, Lozano F, Martínez-Castelao A, Martinez E, Mazuecos MA, Miralles C, Montañes R, Negredo E, Palacios R, Pérez-Elías MJ, Portilla J, Praga M, Quereda C, Rivero A, Santamaria JM, Sanz J, Sanz J, Miró JM.

    Executive summary of the consensus document on the management of renal disease in HIV-infected patients

    NEFROLOGIA . 34(6): 768-788. Number of citations: 1

    [doi:10.3265/Nefrologia.pre2014.Sep.12745]

  • Fortún J, Meije Y, Buitrago MJ, Gago S, Bernal-Martinez L, Pemán J, Pérez M, Gómez-G Pedrosa E, Madrid N, Pintado V, Martín-Dávila P, Cobo J, Fresco G, Moreno S, Cuenca-Estrella M.

    Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients

    The Journal of antimicrobial chemotherapy . 69(11): 3134-3141. Number of citations: 44

    [doi:10.1093/jac/dku225]

  • Pedraza-Flechas AM, García-Comas L, Ordobás-Gavín M, Sanz-Moreno JC, Ramos-Blázquez B, Astray-Mochales J, Moreno-Guillén S.

    Hepatitis B virus infection and vaccine-induced immunity in Madrid (Spain).

    GACETA SANITARIA . 28(6): 492-495. Number of citations: 2

    [doi:10.1016/j.gaceta.2014.05.007]

  • Araujo S, Bañón S, Machuca I, Moreno A, Pérez-Elías MJ, Casado JL.

    Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs

    EUROPEAN JOURNAL OF ENDOCRINOLOGY . 171(5): 545-554. Number of citations: 37

    [doi:10.1530/EJE-14-0337]

  • Rodríguez-Pardo D, Pigrau C, Lora-Tamayo J, Soriano A, del Toro MD, Cobo J, Palomino J, Euba G, Riera M, Sánchez-Somolinos M, Benito N, Fernández-Sampedro M, Sorli L, Guio L, Iribarren JA, Baraia-Etxaburu JM, Ramos A, Bahamonde A, Flores-Sánchez X, Corona PS, Ariza J.

    Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . 20(11): 911-919. Number of citations: 113

    [doi:10.1111/1469-0691.12649]

  • Guionnet A, Navaza B, Pizarro de la Fuente B, Pérez-Elías MJ, Dronda F, López-Vélez R, Pérez-Molina JA.

    Immigrant women living with HIV in Spain: a qualitative approach to encourage medical follow-up

    Bmc Public Health . 14: 1115-1115. Number of citations: 12

    [doi:10.1186/1471-2458-14-1115]

  • Jarrin I, Hernández-Novoa B, Alejos B, Santos I, Lopez-Aldeguer J, Riera M, Gutiérrez F, Rubio R, Antela A, Blanco JR, Moreno S.

    Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen

    HIV MEDICINE . 15(9): 547-556. Number of citations: 6

    [doi:10.1111/hiv.12144]

  • Pinzone MR, Moreno S, Cacopardo B, Nunnari G.

    Is There Enough Evidence to Use Bisphosphonates in HIV-Infected Patients? A Systematic Review and Meta-analysis

    AIDS REVIEWS . 16(4): 213-222. Number of citations: 20

  • Górriz JL, Gutiérrez F, Trullas JC, Arazo P, Arribas JR, Barril G, Cervero M, Cofan F, Domingo P, Estrada V, Fulladosa X, Galindo MJ, Gracia S, Iribarren JA, Knobel H, López-Aldeguer J, Lozano F, Martínez-Castelao A, Martínez E, Mazuecos MA, Miralles C, Montañés R, Negredo E, Palacios R, Pérez-Elías MJ, Portilla J, Praga M, Quereda C, Rivero A, Santamaría JM, Sanz J, Sanz J, Miró JM.

    Consensus document on the management of renal disease in HIV-infected patients

    NEFROLOGIA . 34(2): 1-81. Number of citations: 12

    [doi:10.3265/Nefrologia.pre2014.Jul.12674]